The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (≤3 cm) detection

National Medical Journal of China

Volumn 89, Issue 9, 2009, Pages 592-596

  Xu, Peng Ju ^a   Yan, Fu Hua ^b   Wang, Jian Hua ^b   Lin, Jiang ^b   Ji, Yuan ^b   Chen, Cai Zhong ^b   Shen, Ji Zhang ^b   Li, Ren Chen ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Contrast media; Liver diseases; Liver neoplasms; Magnetic resonance imaging

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CHRONIC LIVER DISEASE; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADULT; COMPARATIVE STUDY; FEMALE; LIVER DISEASE; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; ROC CURVE;

CONTRAST MEDIUM;

ADULT; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 77954911811     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issu.0376-2491.2009.09.004     Document Type: Article

References (16)

1. Brown JJ, Naylor MJ, Yagan M. Imaging of hepatic cirrhosis. Radiology, 1997,202:1-16.
2. Marrrero JA. Hepatocellular carcinoma. Curr Opin Gastroenterol, 2005,21:308-312.
3. Kim YK, Kim CS, Chung GH, et al. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol, 2006,186:149-157.
4. Bhartia B, Ward J, Guthrie JA, et al. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol, 2003,180:577-584. (Pubitemid 36237194)
5. Simon G, Link TM, Wortler K, et al. Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging. Eur Radiol, 2005,15:895-903.
6. Kubaska S, Sahani DV, Saini S, et al. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Clin Radiol, 2001,56:410-415.
7. Naganawa S, Sato C, Nakamura T, et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging, 2005,21:836-840.
8. Kim YK, Kwak HS, Han YM, et al. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography. J Comput Assist Tomogr, 2007,31:702-711.
9. Earls JP, Theise ND, Weinreb JC, et al. Dysplastic nodules and hepatocellular carcinoma: thin section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology, 1996,201:207-214.
10. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenbanced and gadolinium-enhanced MRI. J Magn Reson Imaging, 2007,25:848-858.
11. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol, 2004,183:677-680. (Pubitemid 39145314)
12. Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology, 2003,226:71-78.
13. Ferrell LO, Crawford JM, Dhillon AP, et al. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol, 1993,17:1113-1123.
14. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology, 2005,237:938-944.
15. Baron RL, Peterson MS. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics, 2001,21:S117-132.